1. Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation due to adverse events
- Author
-
Ballerini, Veronica, Bornkamp, Björn, Mattei, Alessandra, Mealli, Fabrizia, Wang, Craig, and Zhang, Yufen
- Subjects
Statistics - Applications ,Statistics - Methodology - Abstract
In clinical trials, patients sometimes discontinue study treatments prematurely due to reasons such as adverse events. Treatment discontinuation occurs after the randomisation as an intercurrent event, making causal inference more challenging. The Intention-To-Treat (ITT) analysis provides valid causal estimates of the effect of treatment assignment; still, it does not take into account whether or not patients had to discontinue the treatment prematurely. We propose to deal with the problem of treatment discontinuation using principal stratification, recognised in the ICH E9(R1) addendum as a strategy for handling intercurrent events. Under this approach, we can decompose the overall ITT effect into principal causal effects for groups of patients defined by their potential discontinuation behaviour in continuous time. In this framework, we must consider that discontinuation happening in continuous time generates an infinite number of principal strata and that discontinuation time is not defined for patients who would never discontinue. An additional complication is that discontinuation time and time-to-event outcomes are subject to administrative censoring. We employ a flexible model-based Bayesian approach to deal with such complications. We apply the Bayesian principal stratification framework to analyse synthetic data based on a recent RCT in Oncology, aiming to assess the causal effects of a new investigational drug combined with standard of care vs. standard of care alone on progression-free survival. We simulate data under different assumptions that reflect real situations where patients' behaviour depends on critical baseline covariates. Finally, we highlight how such an approach makes it straightforward to characterise patients' discontinuation behaviour with respect to the available covariates with the help of a simulation study.
- Published
- 2023